文献速递认知障碍与痴呆帕金森病与运动障碍

额颞叶变性中共存路易体病与临床帕金森综合征

Coexisting Lewy body disease and clinical parkinsonism in frontotemporal lobar degeneration.
PubMed 文献 · Neurology · 2019-04-24

该研究在悉尼脑库126例额颞叶变性(FTLD)队列中筛查共存的多系统萎缩(MSA)和路易体病(LBD,Braak≥IV期)病理,未发现MSA病理;9例存在共存LBD,涉及不同FTLD亚型,所有FTLD-TDP共存LBD病例携带颗粒蛋白前体或C9orf72突变,FTLD-tau共存LBD均为散发;共存LBD的FTLD病例临床异质性明显,但发病年龄和病程与纯FTLD或纯LBD无差异。

要点

  • FTLD队列中约7%(9/126)存在共存LBD病理,未发现MSA病理。
  • FTLD-TDP共存LBD病例均携带颗粒蛋白前体或C9orf72突变。
  • 共存LBD的FTLD病例临床可表现为痴呆或运动障碍,部分出现帕金森综合征。

核心结论

  • 共存LBD在FTLD中占比较小,但对临床和神经病理诊断及生物标志物识别有影响。

研究设计与样本

  • 悉尼脑库前瞻性随访的FTLD-tau和FTLD-TDP病例共126例,筛查共存MSA和LBD(Braak≥IV期)病理,并分析临床和遗传关联。

主要发现

  • 未发现MSA病理。
  • 9例存在共存LBD≥Braak IV期,涉及Pick病(n=2)、皮质基底节变性(n=2)、进行性核上性麻痹(n=2)和TDP A型(n=3)。
  • 所有FTLD-TDP共存LBD病例携带颗粒蛋白前体突变(n=2)或C9orf72重复扩增(n=1),FTLD-tau共存LBD均为散发。
  • 可基因分型的6例均携带H1H1 MAPT单倍型。
  • 7例以痴呆为主,其中3例出现帕金森综合征;2例以运动障碍起病,病程中出现痴呆。

临床怎么用

  • 对FTLD患者应警惕共存LBD可能,尤其FTLD-TDP伴颗粒蛋白前体或C9orf72突变者。
  • 临床出现帕金森综合征或痴呆与运动障碍重叠时,需考虑共存LBD病理。

局限性

  • 样本来自单一脑库,共存LBD病例数较少(n=9),结论外推需谨慎。
  • 未报告生物标志物验证数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To investigate the prevalence of clinically relevant multiple system atrophy (MSA) and Lewy body disease (LBD) pathologies in a large frontotemporal lobar degeneration (FTLD) cohort to determine if concomitant pathologies underlie the heterogeneity of clinical features. METHODS: All prospectively followed FTLD-tau and FTLD-TDP cases held by the Sydney Brain Bank (n = 126) were screened for coexisting MSA and LBD (Braak ≥ stage IV) pathology. Relevant clinical (including family history) and genetic associations were determined. RESULTS: MSA pathology was not identified in this series. Of the FTLD cohort, 9 cases had coexisting LBD ≥ Braak stage IV and were associated with different FTLD subtypes including Pick disease (n = 2), corticobasal degeneration (n = 2), progressive supranuclear palsy (n = 2), and TDP type A (n = 3). All FTLD-TDP cases with coexisting LBD had mutations in progranulin (n = 2) or an abnormal repeat expansion in C9orf72 (n = 1). All FTLD-tau cases with coexisting LBD were sporadic. The H1H1 MAPT haplotype was found in all cases that could be genotyped (n = 6 of 9). Seven cases presented with a predominant dementia disorder, 3 of which developed parkinsonism. Two cases presented with a movement disorder and developed dementia in their disease course. The age at symptom onset (62 ± 11 years) and disease duration (8 ± 5 years) in FTLD cases with coexisting LBD did not differ from pure FTLD or pure LBD cases in the brain bank. CONCLUSION: Coexisting LBD in FTLD comprises a small proportion of cases but has implications for clinical and neuropathologic diagnoses and the identification of biomarkers.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Forrest SL, Crockford DR, Sizemova A, et al. Coexisting Lewy body disease and clinical parkinsonism in frontotemporal lobar degeneration. Neurology. 2019. PMID: 31019099. doi:10.1212/WNL.0000000000007530

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。